These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 32975643)

  • 1. "I think that a brief conversation from their provider can go a very long way": Patient and provider perspectives on barriers and facilitators of genetic testing after ovarian cancer.
    Mallen AR; Conley CC; Fuzzell L; Ketcher D; Augusto BM; McIntyre M; Barton LV; Townsend MK; Fridley BL; Tworoger SS; Wenham RM; Vadaparampil ST
    Support Care Cancer; 2021 May; 29(5):2663-2677. PubMed ID: 32975643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer Genetic Counseling and Testing: Perspectives of Epithelial Ovarian Cancer Patients and Gynecologic Oncology Healthcare Providers.
    Liang MI; Wong DH; Walsh CS; Farias-Eisner R; Cohen JG
    J Genet Couns; 2018 Feb; 27(1):177-186. PubMed ID: 28785836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implementation of a quality improvement project for universal genetic testing in women with ovarian cancer.
    Uyar D; Neary J; Monroe A; Nugent M; Simpson P; Geurts JL
    Gynecol Oncol; 2018 Jun; 149(3):565-569. PubMed ID: 29653687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Why Is Cancer Genetic Counseling Underutilized by Women Identified as at Risk for Hereditary Breast Cancer? Patient Perceptions of Barriers Following a Referral Letter.
    Kne A; Zierhut H; Baldinger S; Swenson KK; Mink P; Veach PM; Tsai ML
    J Genet Couns; 2017 Aug; 26(4):697-715. PubMed ID: 27826805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Embedding a genetic counselor into oncology clinics improves testing rates and timeliness for women with ovarian cancer.
    Rana HQ; Kipnis L; Hehir K; Cronin A; Jaung T; Stokes SM; Fekrmandi F; Vatnick D; Matulonis UA; Garber JE; Wright AA
    Gynecol Oncol; 2021 Feb; 160(2):457-463. PubMed ID: 33229043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Barriers and facilitators to genetic testing for breast and ovarian cancer amongst Black African women in Luton (UK).
    Kabeya V; Puthussery S; Furmanski A
    J Genet Couns; 2024 Apr; 33(2):425-444. PubMed ID: 37403830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of telephone genetic counselling to facilitate germline BRCA1/2 testing in women with high-grade serous ovarian cancer.
    Tutty E; Petelin L; McKinley J; Young MA; Meiser B; Rasmussen VM; Forbes Shepherd R; James PA; Forrest LE
    Eur J Hum Genet; 2019 Aug; 27(8):1186-1196. PubMed ID: 30962500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medical mistrust influences black women's level of engagement in BRCA 1/2 genetic counseling and testing.
    Sheppard VB; Mays D; LaVeist T; Tercyak KP
    J Natl Med Assoc; 2013; 105(1):17-22. PubMed ID: 23862292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Germline BRCA1/2 testing practices in ovarian cancer: Current state and opportunities for new directions.
    Lheureux S; Karakasis K; Harter P; Scott C; Bacon M; Bryce J; Le Fur N; Pujade-Lauraine E; Oza AM
    Gynecol Oncol; 2016 Jan; 140(1):90-4. PubMed ID: 26475959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increasing genetic counseling referral rates through bundled interventions after ovarian cancer diagnosis.
    Swanson CL; Kumar A; Maharaj JM; Kemppainen JL; Thomas BC; Weinhold MR; Slaby KM; Mara KC; Wick MJ; Bakkum-Gamez JN
    Gynecol Oncol; 2018 Apr; 149(1):121-126. PubMed ID: 29402500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Barriers and facilitators to BRCA genetic counseling among at-risk Latinas in New York City.
    Sussner KM; Jandorf L; Thompson HS; Valdimarsdottir HB
    Psychooncology; 2013 Jul; 22(7):1594-604. PubMed ID: 22987526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigating barriers to genetic counseling and germline mutation testing in women with suspected hereditary breast and ovarian cancer syndrome and Lynch syndrome.
    Shaw J; Bulsara C; Cohen PA; Gryta M; Nichols CB; Schofield L; O'Sullivan S; Pachter N; Hardcastle SJ
    Patient Educ Couns; 2018 May; 101(5):938-944. PubMed ID: 29273311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mainstreaming Genetic Testing for Epithelial Ovarian Cancer by Oncology Providers: A Survey of Current Practice.
    Czekalski MA; Huziak RC; Durst AL; Taylor S; Mai PL
    JCO Precis Oncol; 2022 Jan; 6():e2100409. PubMed ID: 35025618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FDA Approval of PARP Inhibitors and the Impact on Genetic Counseling and Genetic Testing Practices.
    Buchtel KM; Vogel Postula KJ; Weiss S; Williams C; Pineda M; Weissman SM
    J Genet Couns; 2018 Feb; 27(1):131-139. PubMed ID: 28780754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Streamlining genetic testing for women with ovarian cancer in a Northern California health care system.
    Powell CB; Laurent C; Ciaravino G; Garcia C; Han L; Hoodfar E; Karlea A; Kobelka C; Lee J; Littell RD; Roh J; Vay A; Kushi LH
    Gynecol Oncol; 2020 Oct; 159(1):221-228. PubMed ID: 32778409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Implementing B-RST
    Wernke K; Bellcross C; Gabram S; Ali N; Stanislaw C
    Clin Breast Cancer; 2019 Aug; 19(4):e547-e555. PubMed ID: 31005475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Facilitated referral pathway for genetic testing at the time of ovarian cancer diagnosis: uptake of genetic counseling and testing and impact on patient-reported stress, anxiety and depression.
    Frey MK; Lee SS; Gerber D; Schwartz ZP; Martineau J; Lutz K; Reese E; Dalton E; Olsen A; Girdler J; Pothuri B; Boyd L; Curtin JP; Levine DA; Blank SV
    Gynecol Oncol; 2020 Apr; 157(1):280-286. PubMed ID: 32057464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Awareness of genetic counseling and genetic testing for hereditary gynecologic cancers among Korean healthcare providers: A survey.
    Kim M; Cheol Lim M; Ji Nam E; Huang D; Kim S; Jong Yoo H; Lee YY; Chang YJ;
    J Genet Couns; 2022 Apr; 31(2):546-553. PubMed ID: 34674340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic Testing in a Population-Based Sample of Breast and Ovarian Cancer Survivors from the REACH Randomized Trial: Cost Barriers and Moderators of Counseling Mode.
    Steffen LE; Du R; Gammon A; Mandelblatt JS; Kohlmann WK; Lee JH; Buys SS; Stroup AM; Campo RA; Flores KG; Vicuña B; Schwartz MD; Kinney AY
    Cancer Epidemiol Biomarkers Prev; 2017 Dec; 26(12):1772-1780. PubMed ID: 28971986
    [No Abstract]   [Full Text] [Related]  

  • 20. Insights into BRCA1/2 Genetic Counseling from Ethnically Diverse Latina Breast Cancer Survivors.
    Rajpal N; Muñoz J; Peshkin BN; Graves KD
    J Genet Couns; 2017 Dec; 26(6):1221-1237. PubMed ID: 28374142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.